טוען...
Trabectedin and its potential in the treatment of soft tissue sarcoma
Trabectedin is a new marine-derived compound that binds the DNA minor groove and interacts with proteins of the DNA repair machinery. Phase I trials have established the standard regimen as 1500 μg/m(2) 24-hour continuous infusion repeated every 3 weeks. Several phase II trials have shown response i...
שמור ב:
Main Authors: | , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Dove Medical Press
2008
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503645/ https://ncbi.nlm.nih.gov/pubmed/18728699 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|